Skip to main content
Fig. 2 | BMC Cancer

Fig. 2

From: Expression characteristic, immune signature, and prognosis value of EFNA family identified by multi-omics integrative analysis in pan-cancer

Fig. 2

Expression level of EFNA family in pan-cancer. A The differential mRNA expression of EFNAs in tumor and normal tissues was evaluated by TCGA combined with GTEx. B The mRNA expression of EFNAs in cancer and para-cancer paired samples in TCGA. C The total mRNA relative expression of EFNAs in pan-cancer. D Protein expression pattern of EFNAs across various cancers in HPA. *p < 0.05, **p < 0.01, ***p < 0.001

Back to article page